Elizaria® ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
62発作性夜間ヘモグロビン尿症2

62. 発作性夜間ヘモグロビン尿症


臨床試験数 : 292 薬物数 : 151 - (DrugBank : 49) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 108
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04671810
(ClinicalTrials.gov)
June 13, 20191/12/2020Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria®Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® in Patients With Paroxysmal Nocturnal Hemoglobinuria.Paroxysmal Nocturnal HemoglobinuriaBiological: Elizaria®AO GENERIUMNULLActive, not recruiting18 YearsN/AAll44Russian Federation
2NCT04463056
(ClinicalTrials.gov)
November 29, 20173/7/2020Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNHA Multicenter, Open Label, Randomized, Parallel-group Study of Efficacy and Safety of Eculizumab (JSC GENERIUM, Russia) vs. Soliris® (Alexion Pharma GmbH, Switzerland) in Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria;Marchiafava-Micheli Syndrome;Paroxysmal HemoglobinuriaBiological: Elizaria®;Biological: Soliris®AO GENERIUMNULLCompleted18 Years75 YearsAll32Phase 3Russian Federation